HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

NASDAQ:HLNE • US4074971064

123.19 USD
+3.22 (+2.68%)
At close: Feb 18, 2026
123.19 USD
0 (0%)
After Hours: 2/18/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

Taking everything into account, HLNE scores 7 out of 10 in our fundamental rating. HLNE was compared to 237 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making HLNE a very profitable company, without any liquidiy or solvency issues. HLNE is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, HLNE could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year HLNE was profitable.
  • In the past year HLNE had a positive cash flow from operations.
  • HLNE had positive earnings in each of the past 5 years.
  • HLNE had a positive operating cash flow in each of the past 5 years.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • With an excellent Return On Assets value of 10.76%, HLNE belongs to the best of the industry, outperforming 86.08% of the companies in the same industry.
  • HLNE has a better Return On Equity (26.61%) than 91.14% of its industry peers.
  • With an excellent Return On Invested Capital value of 16.05%, HLNE belongs to the best of the industry, outperforming 90.72% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for HLNE is significantly above the industry average of 7.29%.
  • The last Return On Invested Capital (16.05%) for HLNE is well below the 3 year average (22.58%), which needs to be investigated, but indicates that HLNE had better years and this may not be a problem.
Industry RankSector Rank
ROA 10.76%
ROE 26.61%
ROIC 16.05%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • HLNE has a better Profit Margin (30.59%) than 74.26% of its industry peers.
  • HLNE's Profit Margin has improved in the last couple of years.
  • The Operating Margin of HLNE (42.80%) is better than 77.64% of its industry peers.
  • In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
Industry RankSector Rank
OM 42.8%
PM (TTM) 30.59%
GM N/A
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, HLNE has more shares outstanding
  • Compared to 5 years ago, HLNE has more shares outstanding
  • HLNE has a worse debt/assets ratio than last year.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.45 indicates that HLNE is not in any danger for bankruptcy at the moment.
  • HLNE has a Altman-Z score of 4.45. This is amongst the best in the industry. HLNE outperforms 83.54% of its industry peers.
  • The Debt to FCF ratio of HLNE is 0.79, which is an excellent value as it means it would take HLNE, only 0.79 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.79, HLNE belongs to the top of the industry, outperforming 89.45% of the companies in the same industry.
  • HLNE has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.32, HLNE is in the better half of the industry, outperforming 70.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 0.79
Altman-Z 4.45
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.20 indicates that HLNE should not have too much problems paying its short term obligations.
  • HLNE has a Current ratio of 1.20. This is comparable to the rest of the industry: HLNE outperforms 54.85% of its industry peers.
  • HLNE has a Quick Ratio of 1.20. This is a normal value and indicates that HLNE is financially healthy and should not expect problems in meeting its short term obligations.
  • HLNE has a Quick ratio of 1.20. This is comparable to the rest of the industry: HLNE outperforms 59.07% of its industry peers.
  • HLNE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.68% over the past year.
  • HLNE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.18% yearly.
  • The Revenue has grown by 10.37% in the past year. This is quite good.
  • HLNE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.08% yearly.
EPS 1Y (TTM)7.68%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%24%
Revenue 1Y (TTM)10.37%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%18.02%

3.2 Future

  • HLNE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.03% yearly.
  • HLNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.64% yearly.
EPS Next Y12.19%
EPS Next 2Y13.41%
EPS Next 3Y16.03%
EPS Next 5YN/A
Revenue Next Year11.26%
Revenue Next 2Y15.6%
Revenue Next 3Y17.64%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 21.96, the valuation of HLNE can be described as rather expensive.
  • 64.56% of the companies in the same industry are cheaper than HLNE, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.27. HLNE is around the same levels.
  • HLNE is valuated rather expensively with a Price/Forward Earnings ratio of 19.00.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HLNE is on the same level as its industry peers.
  • HLNE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.16.
Industry RankSector Rank
PE 21.96
Fwd PE 19
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HLNE is valued a bit cheaper than the industry average as 70.89% of the companies are valued more expensively.
  • 62.45% of the companies in the same industry are more expensive than HLNE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.45
EV/EBITDA 20.25
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLNE does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of HLNE may justify a higher PE ratio.
  • HLNE's earnings are expected to grow with 16.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.8
PEG (5Y)1.09
EPS Next 2Y13.41%
EPS Next 3Y16.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • HLNE has a Yearly Dividend Yield of 1.75%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 6.04, HLNE has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.85, HLNE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.75%

5.2 History

  • On average, the dividend of HLNE grows each year by 19.56%, which is quite nice.
  • HLNE has been paying a dividend for over 5 years, so it has already some track record.
  • As HLNE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • HLNE pays out 36.03% of its income as dividend. This is a sustainable payout ratio.
  • HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.03%
EPS Next 2Y13.41%
EPS Next 3Y16.03%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (2/18/2026, 8:00:01 PM)

After market: 123.19 0 (0%)

123.19

+3.22 (+2.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-03
Earnings (Next)05-27
Inst Owners97.93%
Inst Owner Change3.53%
Ins Owners7.22%
Ins Owner Change-2.76%
Market Cap6.87B
Revenue(TTM)763.40M
Net Income(TTM)233.50M
Analysts80
Price Target181.12 (47.02%)
Short Float %6.07%
Short Ratio4.52
Dividend
Industry RankSector Rank
Dividend Yield 1.75%
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP36.03%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.79%
Min EPS beat(2)14.54%
Max EPS beat(2)37.05%
EPS beat(4)4
Avg EPS beat(4)20.03%
Min EPS beat(4)1.1%
Max EPS beat(4)37.05%
EPS beat(8)7
Avg EPS beat(8)19.57%
EPS beat(12)9
Avg EPS beat(12)12.66%
EPS beat(16)12
Avg EPS beat(16)12.24%
Revenue beat(2)1
Avg Revenue beat(2)2.24%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)5.16%
Revenue beat(4)3
Avg Revenue beat(4)4.79%
Min Revenue beat(4)-0.69%
Max Revenue beat(4)13.69%
Revenue beat(8)6
Avg Revenue beat(8)9.19%
Revenue beat(12)7
Avg Revenue beat(12)5.53%
Revenue beat(16)9
Avg Revenue beat(16)8.49%
PT rev (1m)8.09%
PT rev (3m)10.64%
EPS NQ rev (1m)3.58%
EPS NQ rev (3m)4.22%
EPS NY rev (1m)1.02%
EPS NY rev (3m)11.54%
Revenue NQ rev (1m)2.43%
Revenue NQ rev (3m)2.75%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)4.62%
Valuation
Industry RankSector Rank
PE 21.96
Fwd PE 19
P/S 9
P/FCF 19.45
P/OCF 19.05
P/B 7.83
P/tB 7.83
EV/EBITDA 20.25
EPS(TTM)5.61
EY4.55%
EPS(NY)6.48
Fwd EY5.26%
FCF(TTM)6.33
FCFY5.14%
OCF(TTM)6.47
OCFY5.25%
SpS13.69
BVpS15.73
TBVpS15.73
PEG (NY)1.8
PEG (5Y)1.09
Graham Number44.56
Profitability
Industry RankSector Rank
ROA 10.76%
ROE 26.61%
ROCE 19.19%
ROIC 16.05%
ROICexc 20.06%
ROICexgc 20.65%
OM 42.8%
PM (TTM) 30.59%
GM N/A
FCFM 46.27%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexgc growth 3Y19.01%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 0.79
Debt/EBITDA 0.83
Cap/Depr 77.85%
Cap/Sales 0.99%
Interest Coverage 250
Cash Conversion 107.24%
Profit Quality 151.27%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 4.45
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)7.68%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%24%
EPS Next Y12.19%
EPS Next 2Y13.41%
EPS Next 3Y16.03%
EPS Next 5YN/A
Revenue 1Y (TTM)10.37%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%18.02%
Revenue Next Year11.26%
Revenue Next 2Y15.6%
Revenue Next 3Y17.64%
Revenue Next 5YN/A
EBIT growth 1Y3.1%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year16.07%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y248.08%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y221.14%
OCF growth 3Y21.07%
OCF growth 5Y20.91%

HAMILTON LANE INC-CLASS A / HLNE FAQ

Can you provide the ChartMill fundamental rating for HAMILTON LANE INC-CLASS A?

ChartMill assigns a fundamental rating of 7 / 10 to HLNE.


What is the valuation status for HLNE stock?

ChartMill assigns a valuation rating of 4 / 10 to HAMILTON LANE INC-CLASS A (HLNE). This can be considered as Fairly Valued.


Can you provide the profitability details for HAMILTON LANE INC-CLASS A?

HAMILTON LANE INC-CLASS A (HLNE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for HLNE stock?

The Price/Earnings (PE) ratio for HAMILTON LANE INC-CLASS A (HLNE) is 21.96 and the Price/Book (PB) ratio is 7.83.


How financially healthy is HAMILTON LANE INC-CLASS A?

The financial health rating of HAMILTON LANE INC-CLASS A (HLNE) is 7 / 10.